Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 354 across all filing types
Latest filing 2025-05-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed with the Financial Supervisory Service/Korea Exchange. It details the issuance of new shares, the purpose of the capital increase (operating funds), the third-party allocation method, and the specific terms of the issuance. This falls under the category of announcements regarding new share issues or capital changes.
2025-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document details changes in share ownership, specifically regarding '주식근질권설정변경계약' (changes in stock pledge agreements) by major shareholders and related parties of the company '크레오에스지'. As this is a mandatory disclosure of significant shareholding changes and ownership structure, it falls under the category of Major Shareholding Notification.
2025-05-09 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short, formal announcement regarding a change in the company's market classification (from 'Mid-sized Enterprise' to 'Venture Enterprise') on the stock exchange. It does not contain financial statements, proxy materials, or other detailed reports. As it is a specific regulatory notification regarding company status that does not fit into the other specialized categories, it is classified as a general regulatory filing.
2025-04-30 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a change in the contract amount for a previously disclosed agreement. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2025-04-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status, changes in ownership, and collateral agreements (pledges) of major shareholders and their special related parties. It is not an announcement of a report, but the report itself, and it specifically tracks significant share ownership thresholds. Therefore, it falls under the 'Major Shareholding Notification' category.
2025-04-17 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory disclosure regarding the acquisition of convertible bonds before maturity (redemption). It details the specific bond series, the acquisition amount, the reason (redemption request by the bondholder), and the method of cancellation. This falls under capital structure changes and financing updates, specifically related to debt instruments. Given the specific nature of bond redemption/buyback, it aligns best with the Capital/Financing Update category.
2025-04-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.